NT5DC3 has been shown to suppress cell proliferation and induce cell cycle arrest [63], as well as being an inhibitor of tumour suppressors such as p53 [64], making it an interesting biomarker in the study of ICA, since targeting NT5DC3 could reduce adenosine levels, restore immune function, and enhance the effectiveness of immunotherapies. This evidence concerns the gene TP53 and neoplasm.